A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse (Q83858285)
Jump to navigation
Jump to search
scientific article published on 26 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse |
scientific article published on 26 May 2006 |
Statements
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse (English)
Joseph Moore
Jonathan Kolitz
Wendy Stock
Francis Giles
Matt Kalaycio
David Zenk
Guido Marcucci